INT121470

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.22
First Reported 2004
Last Reported 2010
Negated 1
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 0.54
Pain Relevance 0.07

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Glp1r) plasma membrane (Glp1r) signal transducer activity (Glp1r)
Glp1r (Mus musculus)
Pain Link Frequency Relevance Heat
agonist 4 76.40 Quite High
tolerance 7 49.36 Quite Low
Paracetamol 1 47.76 Quite Low
anesthesia 1 25.00 Low Low
Inflammation 5 5.00 Very Low Very Low Very Low
pruritus 2 5.00 Very Low Very Low Very Low
headache 2 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
fibrosis 1 5.00 Very Low Very Low Very Low
Neuropeptide 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 95 95.72 Very High Very High Very High
Overweight 2 89.32 High High
Body Weight 1 69.44 Quite High
Hyperglycemia 11 42.08 Quite Low
Hypoglycemia 29 28.64 Quite Low
Gastric Motility Disorder 1 11.84 Low Low
Insulin Resistance 16 5.00 Very Low Very Low Very Low
Obesity 10 5.00 Very Low Very Low Very Low
Atherosclerosis 10 5.00 Very Low Very Low Very Low
Heart Rate Under Development 9 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The increase in glucagon-like peptide-1 (GLP-1) levels after gastric glucose was not altered by milrinone.
Neg (not) Regulation (altered) of Positive_regulation (increase) of glucagon-like peptide-1
1) Confidence 0.22 Published 2004 Journal Eur. J. Pharmacol. Section Abstract Doc Link 15364011 Disease Relevance 0 Pain Relevance 0
To overcome the rapid degradation of GLP-1 by DPP-4,127 two approaches have been developed, ie, alteration of the peptide structure of GLP-1 to prevent its degradation by DPP-4, but allow GLP-1 receptor activation, and development of DPP-4 inhibitors, which block the degradation of GLP-1 by DPP-4, thus increasing the reduced concentrations of GLP-1 back to normal physiologic levels in T2DM.
Regulation (alteration) of Positive_regulation (activation) of GLP-1 associated with diabetes mellitus
2) Confidence 0.08 Published 2010 Journal Vascular Health and Risk Management Section Body Doc Link PMC2941781 Disease Relevance 0.54 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox